Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Flecainide in the treatment of nonsustained ventricular tachycardia
R. Lal
, P. D. Chapman
, G. V. Naccarelli
,
K. B. Schechtman
, R. L. Rinkenberger
, P. J. Troup
, S. S. Kim
, A. H. Dougherty
, R. Ruffy
Institute for Informatics, Data Science and Biostatistics (I2DB)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Flecainide in the treatment of nonsustained ventricular tachycardia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Flecainide
100%
Nonsustained Ventricular Tachycardia
100%
Drug Levels
66%
Organic Heart Disease
66%
Heart Failure
33%
Left Ventricular Ejection Fraction
33%
Arrhythmia
33%
Antiarrhythmic Drugs
33%
Treatment Initiation
33%
Ventricular Tachycardia
33%
Proarrhythmia
33%
Serious Adverse Effects
33%
Unsuccessful Treatment
33%
Flecainide Acetate
33%
Medicine and Dentistry
Flecainide
100%
Nonsustained Ventricular Tachycardia
100%
Heart Disease
66%
Heart Left Ventricle Ejection Fraction
33%
Congestive Heart Failure
33%
Antiarrhythmic Agent
33%
Cardiac Dysrhythmia
33%
Electrocardiogram
33%
Ventricular Tachycardia
33%
Proarrhythmia
33%
Flecainide Acetate
33%
Adverse Effect
33%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Tachycardia
100%
Flecainide
100%
Heart Disease
50%
Congestive Heart Failure
25%
Heart Arrhythmia
25%
Antiarrhythmic Agent
25%
Heart Proarrhythmia
25%
Flecainide Acetate
25%